|
|
Nicole Brandt, PharmD |
Amy Davidoff |
Thomas Shaffer, MHS
Linda Simoni-Wastila, BSPharm, PhD
Bruce Stuart, PhD | Lirong Zhao
Ilene
Zuckerman, PharmD, PhD
Linda
Simoni-Wastila, BSPharm, PhD
Linda
Simoni-Wastila, BSPharm, PhD is an Associate
Professor at the University of Maryland-Baltimore, School of Pharmacy
and Director of the Long-Term Care Initiative at the Lamy
Center.
She also holds a faculty appointment at the University
of Massachusetts School of Medicine in Worcester, Massachusetts.
Dr.
Simoni-Wastila has been involved in research focusing on prescription
drugs for over 15 years. As a health services researcher,
she has examined issues including access to prescription drugs,
outcomes related to reduced prescription drug access, cost
and financing of prescription drug benefits and programs,
appropriateness of drug prescribing, outcomes associated with
inappropriate prescribing, and prescription drug misuse and
abuse. She is particularly interested in the impacts of limited
prescription drug use and inappropriate drug use in vulnerable
populations, including elders, racial and ethnic minorities,
and those at risk due to impaired physical and mental health.
Her current research portfolio includes Quality of
Pharmacologic
Treatment of Mental Illness in Long-term Care Recipients,
Prescription Drug Issues Under the New Medicare
Prescription Drug Benefit and the Prescription Drug
Use, Abuse, and Outcomes. She has received grants and contracts from the National Institute
on Drug Abuse, National Institute on Alcohol Abuse and Alcoholism,
the Agency for Healthcare Research and Quality (formerly the
Agency for Health Care Policy and Research), the Centers for
Medicare and Medicaid Services, and various states, foundations
and proprietary firms.
Dr.
Simoni-Wastila received her undergraduate pharmacy degree
from the University of North Carolina, where she also completed
a Master’s in Public Health policy. In 1993, she received
her doctorate in Health Policy from Brandeis University. Most
recently, she was a Senior Scientist at the Schneider Institute
for Health Policy at Brandeis University where, in addition
to her research, she was Co-Director of a doctoral training
program sponsored by NIAAA.
Linda
Simoni-Wastila can be reached at 410-706-4352 or emailed at
lsimoniw@rx.umaryland.edu.
Recent Publications:
Simoni-Wastila L
and
Yang, H-W K.
Psychoactive Drug Use in Older Adults.
American Journal of
Geriatric Pharmacotherapy. December 2006; (494):
380-394
Simoni-Wastila L,
Stuart B, and Shaffer T. Over-the-Counter drug use by
Medicare beneficiaries in nursing homes: implications
for practice and policy.
Journal of the American
Geriatrics Society.
2006;
(54): 1543-1549
Zerzan JT, Morden N,
Soumerai SB, Ross-Degnan D, Roughead E, Zhang F,
Simoni-Wastila L,
and Sullivan SD. Trends and geographic variation of
opiate medication use in state Medicaid fee-for-service
programs.
Medical Care.
November 2006; 44(11): 1005-1010
Zuckerman I, Langenberg P,
Orwig D, Baumgarten M, Byrns P,
Simoni-Wastila L,
Magaziner J. Inappropriate drug use and risk of
transition to nursing homes among community-dwelling
older adults.
Medical Care. August 2006; 44(98):722-30.
Simoni-Wastila L,
Zuckerman I, Singhal PK, Briesacher B, Hsu VD. National
estimates of exposure to prescription drugs with
addiction potential in the Medicare population.
Substance Abuse.
2006;26(1): 33-42.
Pearson
S-A, Soumerai S, Mah C, Zhang F,
Simoni-Wastila L,
Salzman C, Cosler LE, Fanning T, Gallagher P, Ross-Degnan
D. Racial disparities in access following regulatory
surveillance of benzodiazepines.
Archives of Internal
Medicine. March 13, 2006; 166:572-579.
Stuart B,
Simoni-Wastila L,
Shaffer T, Baysac F, Shea D. Coverage and Use of
Prescription Drugs in Nursing Homes: Implications for
the Medicare Modernization Act.
Medical Care.
March 2006; 44(3):243-249.
Briesacher, B. A., Limcangco, M. R., Simoni-Wastila, L.,
Doshi, J. A., Levens, S. R., Shea, D. G., et al. (2005). The
quality of antipsychotic drug prescribing in nursing homes.
Arch Intern Med, June
2005; 165:1280-1285.
Briesacher, B., Limcangco, R., Simoni-Wastila, L.,
Doshi, J., & Gurwitz, J. (2005). Evaluation of nationally
mandated drug use reviews to improve patient safety in nursing
homes: a natural experiment. J Am Geriatr Soc, 53(6),
991-996.
Stuart, B., Simoni-Wastila, L.,
& Chauncey, D. (2005). Assessing The Impact Of Coverage Gaps
In The Medicare Part D Drug Benefit. Health Aff (Millwood).
|
|